Star Seyedkazemi
Corporate Officer/Principal at ADVERUM BIOTECHNOLOGIES, INC.
Net worth: 67 405 $ as of 2024-03-30
Profile
Star Seyedkazemi is currently the Chief Development Officer at Adverum Biotechnologies, Inc. Prior to this, Star held the position of Senior Director-Clinical Research at Tobira Therapeutics, Inc. from 2015 to 2016.
Star then worked at Allergan, Inc. as an Associate Vice President-Clinical Development from 2018 to 2020.
Star also served as an Associate Vice President at AbbVie, Inc. Star's most recent former position was as Vice President-Portfolio Management at Pliant Therapeutics, Inc. from 2020 to 2021.
Star obtained an undergraduate degree from Florida Atlantic University and a doctorate degree from Nova Southeastern University, Inc.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-02-11 | 4,767 ( 0.02% ) | 67 405 $ | 2024-03-30 |
Star Seyedkazemi active positions
Companies | Position | Start |
---|---|---|
ADVERUM BIOTECHNOLOGIES, INC. | Corporate Officer/Principal | 2022-01-05 |
Former positions of Star Seyedkazemi
Companies | Position | End |
---|---|---|
PLIANT THERAPEUTICS, INC. | Corporate Officer/Principal | 2021-11-30 |
ALLERGAN, INC. | Corporate Officer/Principal | 2020-09-30 |
TOBIRA THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 2016-10-31 |
ABBVIE INC. | Corporate Officer/Principal | - |
Training of Star Seyedkazemi
Florida Atlantic University | Undergraduate Degree |
Nova Southeastern University, Inc. | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
ABBVIE INC. | Health Technology |
ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
PLIANT THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Tobira Therapeutics, Inc.
Tobira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on October 6, 2006 and is headquartered in Madison, NJ. | Health Technology |
- Stock Market
- Insiders
- Star Seyedkazemi